HIVAging-1.gif Back grey_arrow_rt.gif
 
HIV and Aging Selected Articles
 
null.gif
 
 
  1. Aging of HIV-Infected: a explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too - Commentary by Jules Levin - (04/04/17)
     
  2. Aging in US - Worse Still To Come - polypharmacy, multiple comorbidities, decreased survival, impaired daily activities functioning - (12/21/16)
     
  3. Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures: 'HIV Atrophies Brain Despite HAART/HIV Aged Brain 17 Yrs Faster/Evaluation Tests' - (12/07/16)
     
  4. HIV & Aging - Mental Needs: Policy, Mental Health Services Program, Comorbidities, Services for Aging/Older HIV+ - (09/29/14)
     
  5. EATG Aging / HIV Project - Europe Addressing HIV & Aging - there is no such project in the USA. - (07/19/18)
     
  6. Aging/HIV - Gilead RFPs - (07/10/18)
     
  7. Loneliness in Older Adults Living with HIV (58%) - (06/7/18)
     
  8. Cancer risk among the HIV-infected elderly in the United States - (06/22/18)
     
  9. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination - (05/15/18)
     
  10. Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents - (05/14/18)
     
  11. HIV-infected people are living for years, but age-related diseases set in early - (04/23/18)
     
  12. Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood - (03/12/18)
     
  13. How Exercise May Help Protect Your Brain From Cognitive Decline and Dementia - (03/12/18)
     
  14. Aging in HIV-Infected Subjects: A New Scenario and a New View - (03/05/18)
     
  15. HIV+ Women - Frailty / Falls / Fracture / Mortality - (03/02/18)
     
  16. Bone Mineral Density and Parathyroid Hormone as Independent Risk Factors for Mortality in Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study in Brazil. The São Paulo Ageing & Health (SPAH) Study - (02/26/18)
     
  17. Find drugs that delay many diseases of old age: class of drugs called geroprotectors / European Aging Researchers Unite for Aging Drug Development - (02/26/18)
     
  18. HIV: ageing, cognition and neuroimaging at 4-year follow-up - 'Accelerated Brain Aging' - (02/15/18)
     
  19. HIV Accelerates Brain Damage ; "Neurological Complications of HIV Infection" Review - (02/06/18)
     
  20. MitoQ - An antioxidant to attenuate aortic aging / Mitochondria Treatment - (01/31/18)
     
  21. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes - (01/31/18)
     
  22. Changes in viral suppression status among US HIV-infected patients receiving care - (01/31/18)
     
  23. Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications - (01/31/18)
     
  24. Viral Suppression Patterns Among Persons in the United States With Diagnosed HIV Infection in 2014 - CDC - (01/31/18)
     
  25. HIV & PTSD, Lifetime Trauma/Mental Health, Adherence - Aged HIV+ Deserve Better - (01/29/18)
     
  26. WIHS HIV+ Women - More falls, comorbidities, cognitive impairment, isolation/loneliness, self-stigma, detectable viral load; CDC Viral Suppression is Over Estimated in the USA - (01/29/18)
     
  27. Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression - (01/29/18)
     
  28. Forgotten Aging HIV+ - An Explosive Devastating Problem Being Ignored - its scandalous - (01/24/18)
     
  29. Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in MenThe Cooper Center Longitudinal Study - (01/24/18)
     
  30. Ten Take-Home Lessons From Top HIV-Aging Articles in 2017 - (01/22/18)
     
  31. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study - (01/11/18)
     
  32. Accelerated Brain Aging: WHICH IS IT - No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project - OR - Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60 - (01/05/18)
     
  33. Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? - (01/03/18)
     
  34. Suicide in Aging Older HIV+ / Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey - France - (01/03/18)
     
  35. Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers....[20% diabetes, 44% hypertension, 56% dyslipidemia, HPV, lymphoma & cancers were more prevalent in HIV+, so was stroke] - (12/22/17)
     
  36. Aging / HIV -USA - Time For Integrated Care / Beyond Viral Suppression / Payer Analysis - (12/15/17)
     
  37. Social stress induces neurovascular pathology promoting depression - (12/14/17)
     
  38. EACS: Characterization of the Aging Population Living with HIV in Portugal: a multicentre, observational study to evaluate comorbidities in patients above 50 years of age - AGING POSITIVE - (12/14/17)
     
  39. apoB vs LDL/cholesterol - To help save the heart, is it time to retire cholesterol tests? - (12/13/17)
     
  40. The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue - (12/13/17)
     
  41. EACS: BESIDE - FIRST NATIONWIDE ANALYSIS OF RECREATIONAL/ILLICIT DRUG USE IN HIV-INFECTED INDIVIDUALS IN GERMANY SHOWS HIGH PREVALENCE OF SUBSTANCE ABUSE WITH A POTENTIAL FOR DRUG-DRUG INTERACTIONS WITH ANTIRETROVIRAL THERAPY - (12/13/17)
     
  42. EACS: BESIDE - HIGH PREVALENCE OF COMORBIDITIES AND CONCOMITANT MEDICATION IN HIV-INFECTED PATIENTS IN GERMANY CARRIES A HIGH POTENTIAL FOR DRUG-DRUG INTERACTIONS WITH ANTIRETROVIRAL THERAPY - (12/13/17)
     
  43. EACS: Safety and Efficacy of DTG+RPV in the Phase III SWORD-1 and SWORD-2 Studies: 48 Week Subgroup Analysis by Baseline Third Agent Class and Geographic Location - (12/13/17)
     
  44. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders - (12/11/17)
     
  45. Cancer rates Higher in HIV+ vs HIV- for many but not for all cancers - (12/08/17)
     
  46. County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States - (12/08/17)
     
  47. EACS: Aging in Portugal: The number of PLHIV aged 50+ will double in the next 20 years, representing 80% of the estimated overall prevalence in 2037. The proportion over 70 will increase 4.3 times going from 6% to 26%. - (12/06/17)
     
  48. HIV Stigma / Women /Aging / Relationships / Isolation / Depression-Mental Health / CVD - (12/02/17)
     
  49. Does Social Isolation Predict Hospitalization and Mortality Among HIV+ and Uninfected Older Veterans? [yes] - (12/02/17)
     
  50. European Researchers/Advocates Present HIV/Aging Recommendations/EATG to European Parliament - (12/02/17)
     
  51. Stigma in HIV: 53% Report Social Stigma & 60% Report Self-Stigma.....high levels of depression, anxiety particularly for >50 Years Old - 63% Report 3 or more Comorbidities - (11/20/17)
     
  52. Cardiovascular Disease & Risk Assessment in HIV - Editorial & New Study: "Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV" - (11/20/17)
     
  53. New Hypertension Guidelines say systolic BP 120-129 & diastolic less than 80 are ELEVATED ! - (11/16/17)
     
  54. EACS: Treated people living with HIV show poorer cognitive performance at baseline but similar longitudinal changes over two years compared to appropriately chosen controls - (11/08/17)
     
  55. Reducing Blood Pressure / Hypertension Targets - Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and MortalityA Systematic Review and Network Meta-analysis - (11/08/17)
     
  56. CVD / Hypertension Targets in USA - "Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the Targets" - (11/08/17)
     
  57. IDWeek: HIV in the Brain - MANAGING COMORBIDITIES IN PATIENTS WITH HIV (10/16/17)
     
  58. IDWeek: Similar Frequency of New HIV in US Group 45 or Older vs Younger - (10/11/17)
     
  59. AGE: Aging and Antiretroviral Neurotoxicity - - (10/11/17)
     
  60. AGE: Adherence to Recommendations from Comprehensive Geriatric Assessment in an HIV+ Population - written by Mark Mascolini - (10/04/17)
     
  61. AGE: Cognitive Impairment in Symptomatic HIV over age 60 - written by Mark Mascolini - (10/04/17)
     
  62. AGE: Limited evidence of biological aging in early-treated HIV-infected children - written by Mark Mascolini - (10/04/17)
     
  63. AGE: Lean Mass Declines Consistently Over 10 Years in HIV-Infected Adults on Antiretroviral Therapy, with Patterns Differing by Sex - written by Mark Mascolini - (10/04/16)
     
  64. AGE: Metformin suppresses human CMV infection - written by Mark Mascolini - (09/27/17)
     
  65. AGE: Antiretroviral Therapy Does Not Dial Back Advanced Epigenetic Age With HIV - written by Mark Mascolini - (10/03/17)
     
  66. HIV Prematurely Ages the Brain: "Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study" - (10/02/17)
     
  67. Sclerostin Inhibition for Osteoporosis [Romosozumab]- A New Approach - Editorial - (10/02/17)
     
  68. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - (10/02/17)
     
  69. New Bone Drug: Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY™ (Romosozumab) In Postmenopausal Women With Osteoporosis - (10/02/17)
     
  70. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (10/02/17)
     
  71. ECLAIR Study of Cabotegravir (CAB) LA Injections: Characterization of Safety and PK During the "PK Tail" Phase - (10/02/17)
     
  72. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (09/29/17)
     
  73. 2008-2011 / HIV 13 Year Gap Life Expectancy Projected HIV+ vs HIV-Neg: 11 years for Whites; 13 yrs for Blacks; Hispanic 16 yrs. - (09/29/17)
     
  74. Reyataz Reduced CVD Risk - (09/25/17)
     
  75. Mitochondrial energetics in the kidney.... "Hyperglycaemia is the main factor that contributes to the development of diabetic nephropathy" - (09/19/17)
     
  76. Outdated HIV HealthCare Models - high need, aging ignored - (09/18/17)
     
  77. ARTs Brain Penetration: - do we need it? risks? / Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV - (09/15/17)
     
  78. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol - (09/15/17)
     
  79. Aging with HIV: Redesigning healthcare models - (09/13/17)
     
  80. HIV & Sleep Disorders: 100% of HIV+ with cognitive impairment have sleep disorder study reports - (09/11/17)
     
  81. Stigma in HIV+ : 60% experience self-stigma....going along with this is 63% of older HIV+ have 3+ comorbidities which can only worsen stigma & self-stigma - (09/11/17)
     
  82. Aging With HIV: Expert Insights on Complications and Challenges - (09/11/17)
     
  83. Fats/Carbohydrates PURE Study Refuted by AHA - (09/11/17)
     
  84. Fruits, vegetables, and legumes: sound prevention tools  Comment questioning PURE study results - (09/11/17)
     
  85. Fruits, vegetables, and legumes: sound prevention tools - Comment - (09/11/17)
     
  86. Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease and Lung Cancer- CANTOS Study - (09/11/17)
     
  87. Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease and Lung Cancer- CANTOS Study - (09/11/17)
     
  88. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial - (09/09/17)
     
  89. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease - (09/09/17)
     
  90. A5336: Ruxolitinib to Reduce Inflammation - (09/09/17)
     
  91. extra virgin olive oil might be a good food additive to help preserve our 'repairing cells', the EPC: Dark chocolate with olive oil associated with improved cardiovascular risk profile - (09/09/17)
     
  92. Poor sleep is associated with ischaemic heart disease and stroke - (09/09/17)
     
  93. Long acting injectable Cabotegravir for PrEP is in Phase 3 [every 4 or 8 weeks] - (09/09/17)
     
  94. EASL: DNA Methylation Signatures in Blood Show Accelerated Epigenetic Aging in Patients with Nonalcoholic Steatohepatitis Compared to Healthy Controls - (07/07/17)
     
  95. Men With HIV Age Faster According to DNA Methylation Study: "5-year age advancement in HIV/cART individuals....increasing expected mortality risk by 19%" - (07/13/16)
     
  96. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study - (09/01/17)
     
  97. Reassessing the benefits of plant-based eating (PURE) - fruit, vegetables, legumes - CVD risk, mortality - (09/01/17)
     
  98. Stressed brain, stressed heart?..... Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study - (09/01/17)
     
  99. CVD-PCSK9 Repatha Outcomes Study FOURIER - (09/01/17)
     
  100. 3 studies report Hearing Loss in HIV is Worse and Suggests that Aging Worsens Hearing - (09/01/17)
     
  101. Aging with HIV in U.S. Trans NIH Research Themes - (09/01/17)
     
  102. Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients - (09/01/17)
     
  103. HIV & Value Based Healthcare? .....Incorporating Geriatric Consultation Into HIV Care / Employers Plans for Value Based healthcare' - (09/01/17)
     
  104. From One Syndrome to Many: Incorporating Geriatric Consultation Into HIV Care - (09/01/17)
     
  105. Geriatric-HIV Medicine Is Born - Commentary - (09/01/17)
     
  106. Fatty Liver in HIV+ / Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease - (09/01/17)
     
  107. Senescence, Telomerase, Aging HIV - (08/14/17)
     
  108. IAS: Bone Mineral Density at the Hip Declines Twice as Quickly Among HIV-Infected Women than Men - (08/14/17)
     
  109. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy - (08/08/17)
     
  110. HIV - The Brain, Exercise, Diet, Comorbidities, BBB, CNS Penetration, Cure, Interruptions - (08/08/17)
     
  111. Diet/Brain-Heart Connection - (08/08/17)
     
  112. IWCADRH: Clinical Implications of Nonalcoholic Fatty Liver Disease in Patients with HIV Infection - (06/23/17)
     
  113. IAS: Switch to Dolutegravir Noninferior to Continued PI in Older Group With Heart Risk - Mark Mascolini - (08/04/17)
     
  114. IAS: Zoledronic Acid Boosts Bone Density More Than Switch From TDF - Mark Mascolini - (08/03/17)
     
  115. Reyataz Reduced CVD Risk Compared with other ART Regimens - Cardiovascular outcomes among HIV-infected veterans receiving atazanavir: a US national historical cohort study - (07/21/17)
     
  116. IAS: Sub-Study 202094 of SWORD-1 and SWORD-2: Switch From TDF-Containing Regimen to DTG + RPV Improves Bone Mineral Density and Bone Turnover Markers Over 48 Weeks - (07/26/17)
     
  117. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review - (07/22/17)
     
  118. Healthy Plant-Based Diet What Does it Really Mean? Editorial - Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults - (07/22/17)
     
  119. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada - low CD4 at ART initiation reduced life expectancy 20 years - (07/22/17)
     
  120. Life Expectancy in HIV / Reyataz Reduced CVD Risk vs PIs/NNRTIs/Integrase - (07/22/17)
     
  121. CROI: CURE at CROI 2017 - (07/22/17)
     
  122. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60 - (07/19/17)
     
  123. Life Expectancy reduced 20 years If ART Started at < 350 CD4s - Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada - (07/19/17)
     
  124. PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia - (07/19/17)
     
  125. HIV prematurely ages the brain - new study & Commentary - (07/19/17)
     
  126. Repatha Lipodystrophy - (07/19/17)
     
  127. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer - (07/19/17)
     
  128. Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV - (07/19/17)
     
  129. Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy: socioeconomic, neurocognitive impairment, Medicaid/Medicare - exercise, diet, smoking, obesity - (07/19/17)
     
  130. Mental Health in Aging with HIV - Suicide Ideation Will Increase in Aging Older HIV+ - Successful aging and the epidemiology of HIV - (07/19/17)
     
  131. IL-17 Treatment, Anti-Inflammatory in Diabetes/Oral Microbiome - Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity - (07/19/17)
     
  132. AGING CRISIS: Comorbidities Shorten Life & HALE: Healthy Years of Life Expectancy - (05/02/17)
     
  133. "HIV and diabetes may have an additive effect on CKD risk " - HIV & the Aging Kidney - (07/11/17)
     
  134. 2 New HIV CVD/Heart Disease Drugs: PCSK9 inhibitor & 1st CVD Anti-Inflammatory Canakinumab - (07/10/17)
     
  135. HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan - Editorial - (07/10/17)
     
  136. HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms - (07/10/17)
     
  137. HIV & Heart Disease, Cognitive/Neurologic Disease, Bone Disease - (07/10/17)
     
  138. Cancers Now in HIV..."cancer mortality much higher in HIV+" - Cancer-Attributable Mortality Among People With Treated HIV in North America - (07/10/17)
     
  139. Merck to Present New Data from Clinical Trials Evaluating ISENTRESS® HD (raltegravir) and Investigational HIV Therapies Doravirine and MK-8591 at IAS 2017 - (07/10/17)
     
  140. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease / Amgen Offers Refund / 'Value-Pricing' Contract Deals for PCKS9 Cholesterol Drug - (03/22/17)
     
  141. Evolocumab - FOURIER Further cardiovascular Outcomes Research with PCSK9 Inhibition in subjects with Elevated Risk - (05/02/17)
     
  142. Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US - "HIV should be considered a major risk factor for CVD....risk similar to diabetes risk for CVD" - (07/06/17)
     
  143. CVD & Renal Disease Risk in HIV+ / Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults - (07/06/17)
     
  144. Aging / HIV / Latinos - Report Released Illuminating The Needs Of The Forgotten - "Olvidados": A National Health Assessment Of Latinos Growing Older With HIV - (07/06/17)
     
  145. Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection / ACTG HAILO Study - (06/29/17)
     
  146. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial - (06/28/17)
     
  147. IWCADRH: Fat in and around the muscle: metabolism and pathophysiology - (06/26/17)
     
  148. 1st CVD Anti-InflammatoryCanakinumab with Positive Phase 3 Results Announced - Studied in HIV at CROI - (06/26/17)
     
  149. 1st CVD Anti-Inflammatory - Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack - (06/26/17)
     
  150. IWCADRH: Regulation of muscle function and mass by the bone-derived hormone osteocalcin - Brain/Bones/Muscle Exercise Connection/Mortality Too/Comorbidities Workshop-NY 9/16 - (06/23/17)
     
  151. IWCADRH: Clinical Implications of Nonalcoholic Fatty Liver Disease in Patients with HIV Infection - (06/23/17)
     
  152. Aging with HIV in U.S. Trans NIH Research Themes - (06/22/17)
     
  153. Using Imaging to Understand the Role of Epicardial Adipose Tissue in HIV-Related Atherosclerosis - (06/22/17)
     
  154. Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection (13%) - (06/22/17)
     
  155. Types of Myocardial Infarctions in HIV+ - Type 2 vs Type 1 MIs - (06/22/17)
     
  156. Aging & Diabetes - Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010 - YES - (06/21/17)
     
  157. Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine - (06/21/17)
     
  158. Strokes in HIV+ - (06/09/17)
     
  159. Aging/Healthcare Costs-Europe & USA - (06/15/17)
     
  160. CROI: Types of ischemic strokes among HIV-infected individuals across the United States - (06/07/17)
     
  161. Key Select Aging & HIV Reports 2 An entire section on the NATAP website devoted to Aging & HIV. - (06/07/17)
     
  162. Key Aging / HIV Reports 1 of 2 NATAP website devoted to Aging & HIV - (06/07/17)
     
  163. Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome - (06/07/17)
     
  164. Cost of noninfectious comorbidities in patients with HIV - Cost of HIV CARE Increases 5 fold Due to Cost for Comorbidities from <40 to >60 - (03/23/17)
     
  165. Cost of Care in Older Aging patients with Increased Comorbidities......Non-HIV care provider....Aging, Worse Still to Come? - (12/09/16)
     
  166. TREND IN MULTIMORBIDITY AMONG HIV+ ADULTS IN CLINICAL CARE IN THE US - (03/29/17)
     
  167. Aging & HIV - an unaddressed timebomb waiting to explode - slide presentation by Jules Levin, NATAP - (03/14/17)
     
  168. Coronary Aging in HIV-Infected Patients: "Increased vascular age was observed in 162 patients (40.5%), with an average increase of 15 years"...."you are 50 years old but your heart's age is 65"
     
  169. CROI: BIOMARKERS OF AGEING IN HIV-POSITIVE INDIVIDUALS AND MATCHED CONTROLS: 8 years greater biologic age in HIV+ - (02/24/17)
     
  170. IAC: Aging & Inflammation: 10 yrs decreased life expectancy/T-cell activation remind high despite viral suppression/inflammation markers predict disease & death- "Pathophysiology of Non-Communicable Diseases in Treated HIV Infection: Is there a common path?" talk by Peter Hunt - (07/22/16)
     
  171. Biologic aging, frailty, and age-related disease in chronic HIV infection
     
  172. Future challenges for clinical care of an ageing population infected with HIV: a "geriatric-HIV" modelling study - [Healthcare Costs].... Very Sobering Analysis on Aging in HIV+....60% frail
     
  173. Future challenges for clinical care of an ageing population infected with HIV: a ''geriatric HIV'' modeling study
     
  174. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...the proportion of patients aged 60 years or older will increase from 8% to 39%....The ageing HIV-infected population will put new demands on the health-care systems
     
  175. The First HIV/AIDS Generation Reaches Retirement Age
     
  176. Veterans Aging Cohort Study (VACS) Index, Functional Status, and Other Patient Reported Outcomes in Older HIV-positive (HIV+) Adults in SF.....Poor Outcomes in HIV+ Aging age 53-61 - (10/23/14)
     
  177. Geriatric Syndromes in Older HIV-Infected Adults...at 57 age...Participants had a median of 4 (IQR: 3-6) comorbidities & were taking a median of 9 (6-12) nonantiretroviral medications & (53.6%) had 2 or more geriatric syndromes.....http://www.natap.org/2015/HIV/052015_04.htm
     
  178. Decreased Life Expectancy in HIV+
     
  179. Comorbidities & Life Expectancy: the affect of comorbidities on Life Expectancy - (03/15/17)
     
  180. Alarmingly High Comorbidity Rates Among HIV+ - (09/24/15)
     
  181. HIV Infection Prematurely Ages People by an Average of Five Years - (05/12/16)
     
  182. Neurodegeneration and Ageing in the HAART Era....... - (05/10/16)
     
  183. CROI: Neurocognitive Disorders - Neurologic, Brain, Cognitive Impairment - (04/10/17) 20 relevant brain studies at CROI
     
  184. HIV Remodels Brain Function Study Suggests - also: illicit drug use history, comorbidities
     
  185. Aging/HIV IGNORED....The aging survivors left behind by AIDS - (03/09/16)
     
  186. CROI: Cognitive Trajectories in Suppressed HIV Infection Indicate Evolving Disease Activity - (02/24/17)
     
  187. CROI: Frailty Stronger Than Neurocognitive Impairment in Predicting Falls-Disability-Death - (02/26/17)
     
  188. Cancer risk among the HIV-infected elderly in the United States - (06/07/16)
     
  189. CROI: Cognitive Complaints and Development of Falls among HIV-Infected and Uninfected Women - (03/06/17)
     
  190. CROI: CEREBRAL SMALL VESSEL DISEASE IN CART WELL-CONTROLLED HIV-INFECTED PATIENTS ANRS EP51 MICROBREAK - (02/28/17)
     
  191. "aging implicated - body composition, involving both abdominal obesity and stavudine-induced peripheral lipoatrophy, might contribute to the higher prevalence of hypertension in HIV-1-infected patients.....Our results suggest a role for both abdominal fat accumulation and peripheral lipoatrophy in the pathophysiology of hypertension in the context of HIV." - Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure - (06/08/16)
     
  192. SVR Reduces Comorbidities; IDUs Have Greater Immune Activation & Thus are at Greater Risk for Comorbidities & All-Cause Death, and of course HCV & HIV+ are at double the risk - (06/16/16)
     
  193. GLASGOW: COMORBITY IN CHRONIC HIV INFECTION A CASE-CONTROL STUDY IN GERMANY USING HEALTH INSURANCE CLAIMS DATA [Examines 70-80+ Year Olds. Higher Prevalence of Comorbidities in HIV+ vs HIV-neg] - (11/08/16)
     
  194. GLASGOW: HEALTH-RELATED COSTS IN CHRONIC HIV INFECTION: A CASE-CONTROL STUDY VS. GENERAL POPULATION USING A CLAIMS-BASED APPROACH IN GERMANY....healthcare/drug costs soar for HIV+ aging compared to HIV-neg. - (11/08/16)
     
  195. GLASGOW: Changes in the Prevalence of Cardiovascular, Renal and Bone Co-Morbidities and Related Risk Factor in HIV-Infected Patients in The Spanish VACH Cohort: A Cross-Sectional Study in 2010 and 2014.... - (11/09/16)
     
  196. IAC: Neurocognitive Assessment in Nigeria The ICON Cohort - (08/04/16)
     
  197. HIV infection and vascular stiffness among older-adults taking antiretroviral therapy in rural Uganda.... arterial stiffness occurs more often in HIV+ .....aging/HIV in Africa
     
  198. Premature Aging and Immune Senescence in HIV-1-Infected Children
     
  199. Statins effects in Older Adults Risks/Benefits - Primary Prevention / ALLHAT-LLT Study "patients without atherosclerotic cardiovascular disease" - (05/25/17)
     
  200. Statin Treatment for Older Adults: The Impact of the 2013 ACC/AHA Cholesterol Guidelines - new analysis: "the evidence is lacking for older adults without major cardiovascular risk aside from age" - (05/25/17)
     
  201. Statin (JUPITER study) in Elderly with Relatively Low Risk Factors - (05/25/17)
     
  202. Study Casts Doubt on Need for Statins in the 'Healthy Old' - But specialists cite research flaws, limitations - (05/25/17)
     
  203. Analysis of Efficacy and Safety in Patients Aged 65-75 Years at Randomization [from Jules: relatively low risk] - (05/25/17)
     
  204. Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia - higher mortality, health-care utilization, worse quality of life, more comorbidities/geriatric conditions matched to uninfected - (05/22/17)
     
  205. Marijuana use impacts midlife cardiovascular events in HIV-infected men - (05/17/17)
     
  206. Another statin option in HIV - Comment - (05/17/17)
     
  207. LDL Debate - Role in CVD / Exercise, Diet Inflammation, Mortality - (05/12/17)
     
  208. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects - (05/02/17)
     
  209. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis / CROI: Higher Carnitine Levels Almost quadrupled MI Risk in HIV+ - (05/02/17)
     
  210. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease - A Science Advisory From the American Heart Association - (05/02/17)
     
  211. AGING CRISIS: Comorbidities Shorten Life & HALE: Healthy Years of Life Expectancy - (05/02/17)
     
  212. FOURIER Further cardiovascular Outcomes Research with PCSK9 Inhibition in subjects with Elevated Risk - (05/02/17)
     
  213. Disability among Middle-Aged and Older Persons with HIV Infection - (04/11/17)
     
  214. An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS) - (04/11/17)
     
  215. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients - (04/11/17)
     
  216. From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care - (04/11/17)
     
  217. Grey and white matter abnormalities in treated HIV- disease and their relationship to cognitive function - (04/11/17)
     
  218. Cholesterol Lowering [statins] in Intermediate-Risk Persons without Cardiovascular Disease - (04/11/17)
     
  219. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients - (04/11/17)
     
  220. Aging of HIV-Infected: a explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too - Commentary by Jules Levin - (04/04/17)
     
  221. Lipodystrophy Not Forgotten - Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection - in causing heart disease - (03/29/17)
     
  222. Lipoatrophy, Lipodystrophy - Let's Not Forget their Contribution to Heart Disease in HIV - (03/29/17)
     
  223. Eradication of HCV and non-liver-related non-AIDS-related events (CVD/diabetes/kidney/cancers) in HIV/HCV coinfection - (02/01/17)
     
  224. Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors - (01/30/17)
     
  225. 80% of HIV+ Are Over 45 / 20% over 60 /50% Over 50 in NY, SF, Boston, Florida - (01/27/17)
     
  226. IBALIZUMAB 24-WEEK PIVOTAL PHASE III STUDY RESULTS ACCEPTED AS A LATE BREAKER WILL BE PRESENTED AT CROI 2017 - (01/25/17)
     
  227. TLR9, TLR7 HIV Cure Research - (01/24/17)
     
  228. 2 New Cure HIV Antibodies Studies Reported, Combination 3 Antibodies, Two-Pronged Antibody - (01/24/17)
     
  229. Aging & HIV : "A Call to Action - Uncharted Territory A report into the first generation growing older with HIV" UK Patient Survey Report - (01/24/17)
     
  230. 2 New HIV Antibodies Studies Reported, combining 3 antibodies - (01/24/17)
     
  231. Aging - Death Rates of HIV+ Increase Only in those Over 60 Years Old, in Younger Groups Death Rates Decrease - (01/31/17)
     
  232. 2 New Cure HIV Antibodies Studies Reported, Combination 3 Antibodies, Two-Pronged Antibody - (01/24/17)
     
  233. Aging & HIV : "A Call to Action - Uncharted Territory A report into the first generation growing older with HIV" UK Patient Survey Report - (01/24/17)
     
  234. 2 New HIV Antibodies Studies Reported, combining 3 antibodies - (01/24/17)
     
  235. Darunavir + Genvoya [elvitegravir/cobi/FTC/TAF] in Treatment-Experienced Patients with HIV Drug Resistance - (01/24/17)
     
  236. Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging - (01/20/17)
     
  237. Darunavir + Genvoya [elvitegravir/cobi/FTC/TAF] in Treatment-Experienced Patients with HIV Drug Resistance - (01/18/17)
     
  238. Brisk Walking & Strength Training Reduced Inflammation (CRP) & LDL/total Cholesterol - (01/18/17)
     
  239. HIV Remodels Brain Function Study Suggests - also: illicit drug use history, comorbidities - (01/18/17)
     
  240. Questioned - Statin Recommendations / Risk Calculator / American College of Cardiology/American Heart Association (ACC/AHA) guidelines on assessment of cardiovascular risk1 and on treatment of blood cholesterol - (01/13/17)
     
  241. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults - (01/13/17)
     
  242. CVD Prediction- Diabetes/Lipids/Hypertension - (01/11/17)
     
  243. Diabetes / CVD in HIV+ / Inaccuracy of A1C - (01/11/17)
     
  244. Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network - (01/11/17)
     
  245. Predicting HIV-Life Expectancy, Comorbidities - Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population - (01/11/17)
     
  246. Health & AIDS Spending USA - (01/11/17)
     
  247. CVD Prediction- Diabetes/Lipids/Hypertension - (01/10/17)
     
  248. Medical error-the third leading cause of death in the US - (01/10/17)
     
  249. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/10/17)
     
  250. The Management of Dyslipidemia in CKD: New Analyses of an Expanding Dataset - (01/10/17)
     
  251. Interpretation of the evidence for the efficacy and safety of statin therapy - (01/10/17)
     
  252. Under Estimating HIV Cardiovascular Disease Risk / Association Between HIV and Cardiovascular Diseases - Finding a Solution to Double Jeopardy - (01/10/17)
     
  253. 2014 Statin Safety Task Force - (01/04/16)
     
  254. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/04/16)
     
  255. An assessment by the Statin Muscle Safety Task Force: 2014 update - (01/04/16)
     
  256. Statin Benefit vs Harm - OPINION - (01/04/16)
     
  257. Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) - (01/04/16)
     
  258. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients - The GLAGOV Randomized Clinical Trial - (01/04/16)
     
  259. Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsUS Preventive Services Task Force Recommendation Statement - (01/04/16)
     
  260. Anti-PCSK9 Monoclonal Antibodies: The Future Lipid-Lowering Agent of Choice? - (01/04/16)
     
  261. The Management of Dyslipidemia in CKD: New Analyses of an Expanding Dataset - (01/03/16)
     
  262. Medical error-the third leading cause of death in the US - (01/03/16)
     
  263. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis - (01/03/16)
     
  264. Lipid Management Guidelines for Adults with Chronic Kidney Disease - (01/03/16)
     
  265. Pitavastatin: an overview of the LIVES study - (01/03/16)
     
  266. Pitavastatin: a distinctive lipid-lowering drug - (01/03/16)
     
  267. Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study - (01/03/16)
     
  268. Changes in markers of T cell senescence and exhaustion with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s - (07/08/16)
     
  269. After 52 Weeks, Pitavastatin is Superior to Pravastatin for LDL-C Lowering in Patients with HIV - (12/22/16)
     
  270. HIV-Increased Stroke Rates/50% Higher - (12/22/16)
     
  271. Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post-Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor for Age / Inflammation / Heart Disease Problem in HIV - (12/22/16)
     
  272. Statins Safety - pitavastatin [LIVALO] Product Insert - (12/22/16)
     
  273. Aging in US - Worse Still To Come - polypharmacy, multiple comorbidities, decreased survival, impaired daily activities functioning - (12/21/16)
     
  274. The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin - (12/21/16)
     
  275. HIV cure strategists: ignore the central nervous system at your patients' peril - (12/21/16)
     
  276. ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention - (12/21/16)
     
  277. Aging & Addiction / Substance Abuse - (12/21/16)
     
  278. GLASGOW: Hepatic Steatosis is Highly Prevalent in HIV and Significantly Associated with Diabetes Risk - (12/15/16)
     
  279. PD-1 New Cancer immunotherapy Drugs Success - Adverse Events, HIV - (12/07/16)
     
  280. Nivolumab shows promise in first-ever trial for patients with refractory, metastatic anal cancer - (12/07/16)
     
  281. Efavirenz-Induced Nitric Oxide Affects Mitochondrial Function in Glial Cells - (12/05/16)
     
  282. AASLD: A Prospective Study of The Association of Body Morphometry With Hepatic Steatosis and Fibrosis in HIV-HCV Coinfected Patients - (11/30/16)
     
  283. Aerobic exercise and vascular cognitive impairment - 74 Year Olds with Vascular Cognitive Impairment - (11/11/16)
     
  284. Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults - (11/11/16)
     
  285. Infection-related and -unrelated malignancies, HIV and the aging population....older age, low CD4, viral load, smoking, HBV, [HCV].....Non-HIV Cancers Predicted to Increase - (11/11/16)
     
  286. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy - (11/11/16)
     
  287. Anti-Inflammation New Drug Research / Cure May Not Reverse Inflammation Damage - (11/11/16)
     
  288. IDSA: Long-term Effects of [Omega-3] Ω:-3 Fatty Acids in HIV: a RCT - (11/09/16)
     
  289. GLASGOW: HIV PATIENTS TODAY AND 10 YEARS AGO: DO THEY HAVE THE SAME NEEDS? RESULTS FROM CROSS SECTIONAL ANALYSIS OF ANRS CO3 AQUITAINE COHORT - (11/05/16)
     
  290. GLASGOW: Uncontrolled HIV Tied to NHL But Not Hodgkins in Large D:A:D Study - Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma: The D:A:D study - Mark Mascolini - (11/05/16)
     
  291. Infection-related and -unrelated malignancies, HIV and the aging population....older age, low CD4, viral load, smoking, HBV, [HCV].....Non-HIV Cancers Predicted to Increase - (11/05/16)
     
  292. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy - (11/05/16)
     
  293. GLASGOW: Quantifying the future clinical burden of an ageing HIV-positive population in Italy: a mathematical modelling study - (11/02/16)
     
  294. GLASGOW: Quantifying the future clinical burden of an ageing HIV-positive population in the USA:a mathematical modelling study - (11/02/16)
     
  295. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...... - (11/02/16)
     
  296. IDSA: [35% Taking 12 Comedications !] - Polypharmacy in HIV+ 50 or Older Linked to Lower CD4s, Higher CVD Rate - Evaluating the Effect of Polypharmacy on Outcomes in HIV-Infected Patients Age 50 and Older - Mark Mascolini - (10/31/16)
     
  297. IDSA: Low Endothelial Progenitors Tied to CVD Risk, Activation in Older HIV+ Men - Endothelial Progenitor Cell Production is Suppressed and Associated with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men - Mark Mascolini - (10/31/16)
     
  298. Future challenges for clinical care of an ageing population infected with HIV: a modeling study...... - (10/26/16)
     
  299. GLASGOW: Smoking, Nadir CD4s, and PI Use Tied to Bone Quality in Irish Group - The relative impact of antiretroviral drugs and baseline immune status on bone quality in HIV-positive subjects: results from the HIV UPBEAT cohort - Mark Mascolini - (10/27/16)
     
  300. GLASGOW: Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir - (10/27/16)
     
  301. GLASGOW: Improved kidney function in patients who switch their protease inhibitor from atazanaviror lopinavir to darunavir - (10/27/16)
     
  302. GLASGOW: Kidney Function Improves After Switch From LPV or ATV to DRV - Mark Mascolini (10/27/16)
     
  303. GLASGOW: Third ARV Does Not Affect Safety Gains in Switch From TDF/FTC to TAF/FTC - Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by 3rd Agent - (10/27/16) - Mark Mascolini
     
  304. Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen - (10/18/16)
     
  305. Associations of CSF Iron Biomarkers with Neurocognitive Function Over Time in HIV+ Adults - (10/18/16)
     
  306. Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation - (10/18/16)
     
  307. Raltegravir treatment outcomes among older patients and those with comorbidities: A sub-analysis of the CRICKET study (PN-807) - (10/12/16)
     
  308. Exercise Reduces Cancers / Physical Activity and Digestive System Cancer Risk Still Chasing the Promise - (10/12/16)
     
  309. T-cell Reactivity to Cytomegalovirus, Inflammation, and Frailty in HIV+ and HIV- Men Who Have Sex With Men (MACS) - (10/10/16)
     
  310. Higher CMV Antibody Concentrations are Associated with Older Age and Worse Neurocognitive Performance in Adults Living with HIV Disease - (10/08/16)
     
  311. Mitochondrial DNA damage in brain associated with HIV infection - (10/08/16)
     
  312. Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study - (10/08/16)
     
  313. Caring for Older Adults [aging] with the Human Immunodeficiency Virus....."advance care planning is essential in older adults with HIV" - (10/08/16)
     
  314. HIV+ >65 on Medicare Have 2 Times More Comorbidities vs HIV-neg AND Blacks & Latinos Have 4-Fold Increased Risk for the 5 Comorbidities Examined vs Whites - CDC Report Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection. - (10/08/16)
     
  315. Blood-Brain Barrier Permeability and Neurocognitive Performance in HIV+ Adults.... - (10/07/16)
     
  316. Caring for Older Adults [aging] with the Human Immunodeficiency Virus....."advance care planning is essential in older adults with HIV" - (10/07/16)
     
  317. HIV+ >65 on Medicare Have 2 Times More Comorbidities vs HIV-neg AND Blacks & Latinos Have 4-Fold Increased Risk for the 5 Comorbidities Examined vs Whites - CDC Report Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection. - (10/07/16)
     
  318. Mitochondrial DNA damage in brain associated with HIV infection - (10/07/16)
     
  319. CROI: Unexpectedly High Rate of Intolerance for Dolutegravir in Real Life Setting - (10/08/16)
     
  320. Frailty / Aging Projections in Italy - Future challenges for clinical care of an ageing population infected with HIV: a "geriatric -HIV" modelling study - (10/07/16)
     
  321. AGE: Atherosclerotic CVD Risk Profile of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate - (09/30/16)
     
  322. AGE: Similar E/C/F/TAF Safety and Efficacy in Old vs Younger With Renal Impairment - Geriatric patients - Mark Mascolini - (09/29/16)
     
  323. AGE: Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF) in Older HIV-Infected Virologically-Suppressed Adults - eGFR ≥50 - (09/29/16)
     
  324. AGE: Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF) in Older, HIV-Infected Treatment-Naïve Adults - (09/29/16)
     
  325. AGE: Non-HIV care provider....Aging, Worse Still to Come?....Aging Clinic at Weill-Cornell, NYC; aging $costs in HIV skyrocket - (09/29/16)
     
  326. AGE: People 60 or Older Gain Fewer CD4s on ART Through 48 Months - Mark Mascolini (09/29/16)
     
  327. AGE: Non-HIV care provider....Aging, Worse Still to Come?....Aging Clinic at Weill-Cornell, NYC; aging $costs in HIV skyrocket - (09/29/16)
     
  328. AGE: People 60 or Older Gain Fewer CD4s on ART Through 48 Months - Mark Mascolini (09/29/16)
     
  329. IWCADRH: CT Signals of Chronic Lung Disease in HIV Patients Who Never Smoked - Mark Mascolini - (09/28/16)
     
  330. IWCADRH: Impact of initiation of protease inhibitor/ritonavir on PCSK9 levels in HIV-infected antiretroviral-naïve patients from the ANRS C09 COPANA cohort - Mark Mascolini - (09/27/16)
     
  331. IWCADRH: New Therapies for LDL Management - Mark Mascolini - (09/27/16)
     
  332. IWCADRH: The impact of HIV and smoking status on bone quality: results from HIV-UPBEAT; a prospective cohort study - Mark Mascolini - (09/27/16)
     
  333. IWCADRH: Smoking Activates Neutrophils, Possibly Boosting CVD and Cancer Risk - Mark Mascolini - (09/26/16)
     
  334. IWCADRH: Renal outcomes with EFV + TDF/FTC versus other TDF-containing antiretroviral regimens among HIV-infected Veterans: A national study - (09/26/16)
     
  335. IWCADRH: Tenofovir disoproxil fumarate associated Fanconi syndrome in an HIV uninfected man receiving HIV pre-exposure prophylaxis - (09/26/16)
     
  336. IWCADRH: Renal outcomes with EFV + TDF/FTC versus other TDF-containing antiretroviral regimens among HIV-infected Veterans: A national study - (09/26/16)
     
  337. IWCADRH: Hyperbilirubinemia During ATV/r Initiation May Slow the Progression of Carotid Wall Thickening Through its Effects on Glucose and Lipid Metabolism: - (09/22/16)
     
  338. IWCADRH: (1) Association between bilirubin and cardiovascular and cerebrovascular disease events among persons living with HIV across the US - (2) Association between initial antiretroviral therapy regimen and cardiovascular disease events among persons living with HIV in the US - (09/22/16)
     
  339. IWCADRH: One Third Lower MI Risk With Atazanavir Than Other ARVs in US Veterans - Mark Mascolini - (09/22/16)
     
  340. IWCADRH: Regulation of muscle function and mass by the bone-derived hormone osteocalcin - "Exercise is the only way to preserve muscle function" - (09/22/16)
     
  341. IWCADRH: Three-Day per Week Atripla Maintains Viral Suppression and Decreases Sub-clinical Toxicity: a Pilot Study Three-Times-a-Week Atripla Maintains Viral Suppression in 24-Week Pilot Study - Mark Mascolini - (09/22/16)
     
  342. IWCADRH: Tolerability of integrase inhibitors in a real-life setting - Barcelona - Mark Mascolini - (09/22/16)
     
  343. IWCADRH: Less Inflammation in Metabolically Healthy vs Unhealthy Men With HIV - Associations Between Systemic Inflammatory Perturbations and Metabolic Health Vary by HIV Serostatus and BMI - (09/19/16)
     
  344. IWCADRH: Raltegravir is Associated with Greater Abdominal Fat Increases after Antiretroviral Therapy Initiation Compared to Protease Inhibitors - (09/19/16)
     
  345. IWCADRH: Comparison of CD4+ and CD8+ T Cell Subsets in Blood and Adipose Tissue from HIV-infected Persons on Long-term ART..... "Compared with blood, adipose tissue from HIV+ adults is enriched for activated CD4+ & CD8+ T-cells" - (09/16/16)
     
  346. IWCADRH: HIV duration of 20 Years in 75 year olds Doubles Multimorbidities & Polypharmacy Rates & This Causes Using HAART with Less Drugs in the Regimen - Silver champions from the GEPPO cohort (GEriatricPatients living with HIV/AIDS): a case control study of people above 75 years of age addressing Multimorbidity Polypharmacy and Antiretrovirals' Prescription in old HIV patients. - (09/16/16)
     
  347. IWCADRH: Future challenges for clinical care of an ageing population infected with HIV: a "geriatric-HIV" modelling study - [Healthcare Costs].... Very Sobering Analysis go Aging in HIV+....60% frail - (09/15/16)
     
  348. IWCADRH: Ischemic strokes among HIV-infected individuals in the CNICS cohort: the role of traditional and HIV-related risk factors and the impact of events secondary to other causes - Diabetes, HCV, Lipids, Low CD4s Predict Ischemic Stroke With HIV - (09/15/16)
     
  349. IWCADRH: HIV Boosts Risk of Persistently High ALT After HCV Clearance - "Persistent Aminotransferase Elevation following HCV clearance in Adults with and without HIV" - (09/15/16)
     
  350. IWCADRH: Exercise Reduced Comorbidities Risk A Lot / "the detrimental consequences of inactivity are exacerbated by excess visceral adiposity" - Physical Activity Consistently Linked to Comorbidity in US HIV Group - (09/15/16)
     
  351. IWCADRH: Coronary Endothelial Dysfunction is Present in HIV+ Patients Despite a Zero Coronary Artery Calcium Score and is Related to the Degree of Inflammation and Local Epicardial Fat (heart) - (09/15/16)
     
  352. IWCADRH: Coronary Endothelial Dysfunction is Present in HIV+ Patients Despite a Zero Coronary Artery Calcium Score and is Related to the Degree of Inflammation and Local Epicardial Fat (heart) - (09/14/16)
     
  353. IWCADRH: Heart Disease Prevention Inadequate in Large Older HIV Cohort - Mark Mascolini - (09/14/16)
     
  354. IWCADRH: Australian Study of BMD Changes for Men on PrEP Who Are Adherent to Daily TDF/FTC PrEP - Mark Mascolini - (09/14/16)
     
  355. IWCADRH: BMD and Bone Markers Improve Over 18 Years in Perinatally HIV Infected - Mark Mascolini - (09/14/16)
     
  356. IWCADRH: Slower Bone Growth May Be Risk for Young Men on TDF/FTC PrEP - (09/13/16)
     
  357. IWCADRH: Bone Microarchitecture, Not Just BMD, Worse in Women With Than Without HIV - (09/13/16)
     
  358. IWCADRH: Slower Bone Growth May Be Risk for Young Men on TDF/FTC PrEP - (09/13/16)
     
  359. IWCADRH: More Than 5% BMD Loss With 1 Year of TDF/FTC PrEP in Half of Australian Group - (09/13/16)
     
  360. AGE: Excess Mitochondrial DNA Damage in Brain of People With HIV - written by Mark Mascolini - (09/28/16)
     
  361. AGE: Frailty and the Risk of Falls in HIV-Infected Older Adults in the ACTG A5322 Study - (09/28/16)
     
  362. AGE: Longitudinal Study of Falls among HIV-infected and Uninfected Women: Results from the Women's Interagency HIV Study - (09/28/16)
     
  363. AGE: Worse Neurocognitive Score Tied to Higher CMV, Longer HIV, Lower BP - written by Mark Mascolini - (09/28/16)
     
  364. AGE: Transitions from Disability to Ability: A Qualitative Study to Understand Exercise Barriers in Older, HIV-Infected Adults - (09/28/16)
     
  365. AGE: Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults....HIV+ have 2-4 times higher rates of impaired ability to perform daily functioning activities vs HIV-negatives - written by Mark Mascolini (10/05/16)
     
  366. AGE: Cognition, Depression, Neuropathy Predict Falls in WIHS Women With or Without HIV - written by Mark Mascolini (10/05/16)
     
  367. AGE: Eliminating Smoking and Hypertension Could Cut MI Rate 20% to 40% in HIV Group - [lack of prevention by providers for HIV+] - written by Mark Mascolini (10/05/16)
     
  368. AGE: Less Physical Activity, Less Education Tied to Daily Living Impairments [Disabilities] in Older HIV Group - ACTG5322 - written by Mark Mascolini (10/05/16)
     
  369. AGE: Up to Half in Older DC Cohort Not Treated for Metabolic Comorbidities - High Burden of Comorbidities in Inner City Washington DC - written by Mark Mascolini (10/05/16)
     
  370. AGE: Resting Metabolic Rate Higher in Older Men With Than Without HIV - written by Mark Mascolini (10/05/16)
     
  371. Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication - (09/23/16)
     
  372. A Novel Perspective on the Biology of Bilirubin in Health and Disease....."Unconjugated bilirubin (UCB) is known to be one of the most potent endogenousantioxidant substances....to ameliorate atherosclerosis, cancer, autoimmunity, and/or neurodegenerative conditions.....BLB has also potent anti-inflammatory activities in brain tissue" - (09/23/16)
     
  373. Impact of Strength Training on Bone Mineral Density in Patients Infected With HIV Exhibiting Lipodystrophy - (09/23/16)
     
  374. Bone & The Brain: osteocalcin predicts brain function - (09/23/16)
     
  375. Brain Growth with Exercise - (09/23/16)
     
  376. Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication - (09/23/16)
     
  377. "Exercise is the only way to preserve muscle function"- Exercise/Brain/Bone/Muscle Connection - (09/23/16)
     
  378. Aging - New drugs - (01/08/16)
     
  379. HIV & HCV & Parkinsons Disease: is there an increased risk - undecided yet with mixed opinions and suggestive data - (01/06/16)
     
  380. EASL: EACS aging-related presentations - (12/18/15)
     
  381. AGE: 6th 2015 Aging Workshop Reports (12/11/15)
     
  382. Aging/Comorbidities Update: New Studies-Publications / Conference Aging Studies: EACS / IDSA / ICAAC / IAS / CROI - (12/10/15)
     
  383. CROI: CROI 2015 - Metabolics / Aging, Senescence / Comorbidities / Inflammation - 3 Exercise Studies / Heart Disease / Statins / Cancers / The Kidney / Bone / TAF / The Brain - neurologic function
     
  384. IDSA: Influence of Age on Outcomes in HIV-Infected Adults Initiating Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate With Elvitegravir, Cobicistat, and Emtricitabine (10/15/15)
     
  385. AGE: Neurocognitive Performance Falls Faster With Age in HIV-Positive People - written by Mark Mascolini (10/09/15)
     
  386. AGE: Depression Tied to Worse Cognitive Function in MACS Men With or Without HIV - written by Mark Mascolini (10/09/15)
     
  387. AGE: Are frailty, precariousness and comorbidity related in HIV-infected aging patient? YES, 65% Frail/Prefrail in French Study/Mean age 57.....at the Aging Workshop Oct 2015 (10/09/15)
     
  388. AGE: Noninfectious Conditions May Drive Neurocognitive Problems With HIV - written by Mark Mascolini (10/09/15)
     
  389. AGE: Older Adults With HIV Spend Most Time Home, Alone, and Passive - written by Mark Mascolini (10/09/15)
     
  390. AGE: Frailty Tied to Cardiometabolic Disorders and Death in Large HIV Cohort - written by Mark Mascolini (10/09/15)
     
  391. AGE: Emphysema Progression Similar With HIV and in Older HIV-Negative Heavy Smokers - written by Mark Mascolini (10/07/15)
     
  392. AGE: CD4/CD8 Ratio Better in HIV+ Women Than Men, But Survival Similar - written by Mark Mascolini (10/07/15)
     
  393. AGE: Rapid Rise in Frailty in First 3 Years of Menopause in HIV+ Women, Then Stable - written by Mark Mascolini (10/07/15)
     
  394. AGE: Frailty Doubles Death/MACS) A frailty-related phenotype and death: Investigating inflammatory markers as potential mediators among men with HIV in the modern HAART era - [Interleukin 6 (IL-6), C-reactive protein (CRP), Tumor necrosis factor-receptor 2 (TNFαR2)] (10/05/15)
     
  395. AGE: Higher Non-AIDS Cancer Rate in Men With HIV: 30-Year MACS Study - written by Mark Mascolini (10/05/15)
     
  396. AGE: Frailty, "Precarious" Status, and Comorbidities Linked in Large French Cohort - written by Mark Mascolini (10/05/15)
     
  397. AGE: Grip Strength Fades Faster With Age in Men With Than Without HIV - written by Mark Mascolini (10/05/15)
     
  398. AGE: Frailty Doubles Death Risk in HIV+ Men, With Only Modest Impact of Inflammation - written by Mark Mascolini (10/05/15)
     
  399. Aging & Comorbidities at ICAAC 2015 & IAS 2015 - (10/02/15)
     
  400. Parkinson Disease in HIV.....Does HIV Infection Alter Parkinson Disease? - (09/24/15)
     
  401. Aging/Comorbities at IAS - (08/18/15)
     
  402. IAS: Aging, Hospitalization Rates for Liver/GI - Rates Increased for Cardiovascular Disease & Non-AIDS Cancers in Italy - Mark Mascolini - (07/29/15)
     
  403. IAS: Age, IDU, Viral Load Testing Rate Predict HIV Control and Rebound in Canadian MSM - written by Mark Mascolini - (07/21/15)
     
  404. HIV in the Older Adult, Aging/Comorbidities & Death in HIV....... "Will You Still Treat Me When I'm 64? Care of the Older Adult With HIV Infection" - (07/17/15)
     
  405. HIV & Aging Accelerated?: .....HIV-infection and comorbidities: a complex mix...... Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study - (07/10/15)
     
  406. HIV & Aging: Psychosocial, mental health, and behavioral issues/services/mental health policy - (07/09/15)
     
  407. Mediterranean Diet/Nuts/Olive Oil Improve Brain Function - (07/08/15)
     
  408. Enhancing Cognitive Aging: Clinical Highlights of a Report From the Institute of Medicine - (07/02/15)
     
  409. Aging, Frailty African-American Women and in IDUs (managing aging & HIV) - (06/19/15)
     
  410. Aging/HIV in Europe - Predictions - (06/11/15)
     
  411. Is HIV a Model of Accelerated or Accentuated Aging? - (06/01/15)
     
  412. AGE: Inflammation/Morbidity/Mortality - Coagulation and Morbidity in Treated HIV Infection - (10/27/14)
     
  413. AGE: The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging - (10/27/14)
     
  414. AGE: HIV, Aging, and Statins: Pros vs. Cons... - (10/27/14)
     
  415. AGE: HCV in Australia "it is the Dallas Buyers Club scenario"...HCV therapy is much less expensive than HIV HAART...... "Australia is on the verge of a catastrophic death spiral from Hepatitis C" - Mark Mascolini (10/24/14)
     
  416. AGE: Health Deficits Accumulate Faster With HIV Than Without in Older Adults - Mark Mascolini - (10/24/14)
     
  417. AGE: Higher Frailty Index Tied to Lower Odds of Successful Cognitive Aging in HIV+ Over 50 - Mark Mascolini - (10/24/14)
     
  418. AGE: Gait Speed Slows More With Age in MACS Men With Than Without HIV - Mark Mascolini - (10/24/14)
     
  419. AGE: Kidney Disease Key Cofactor in Coronary Artery Disease Risk With HIV at 60 and Older - Mark Mascolini - (10/24/14)
     
  420. AGE: Switch From PI or NNRTI to Stribild in People 50 or Older Effective and Safe in Trials - Mark Mascolini - (10/24/14)
     
  421. AGE: PIs and Raltegravir Favored Over NNRTIs for Frail and Older People - Mark Mascolini - (10/24/14)
     
  422. AGE: Testosterone Lower in AM But Not PM in MACS Men With vs Without HIV - (10/23/14)
     
  423. AGE: Diastolic Dysfunction Tied to Impaired Exercise Capacity in Older Men With HIV - (10/23/14)
     
  424. HIV & Aging: Failure to Normalize Immunity Despite Decade of Successful HAART - (06/16/14)
     
    HIV & Aging: HIV and the aging kidney - (06/16/14)
     
    HIV & Aging: Biologic aging, frailty, and age-related disease in chronic HIV infection - (06/16/14)
     
    HIV & Aging: Immunosenescence and aging in HIV - (06/16/14)
     
    HIV & Aging: Update on metabolic issues in HIV patients - (06/16/14)
     
    HIV & Aging: Coping styles and illicit drug use in older adults with HIV/AIDS - (06/16/14)
     
    HIV & Aging: Psychosocial, mental health, and behavioral issues of aging with HIV - (06/16/14)
     
    HIV & Aging: Demographics of HIV and aging - (06/16/14)
     
    HIV & Aging: African Americans, Hispanics, Caucasians (2 MACS Studies) - (06/09/14)
     
  425. CROI: Metabolics and Aging at CROI 2014 - David Alain Wohl, MD - The University of North Carolina - (04/06/14)
     
  426. CROI: Abdominal Obesity, Inflammation, Immune Activation and Neurocognitive Impairment - (03/19/14)
     
  427. Decline in locomotor functions over time in HIV-infected patients - (02/26/14)
     
  428. AGE: Poor Physical Function in Older Women on ART Tied to Comorbidities, Inflammation - Written by Mark Mascolini - (11/14/13)
     
  429. AGE: Prescriptions Rise With Age in Ontario HIV+, But Drug-Related Problems Don't - Written by Mark Mascolini - (11/14/13)
     
  430. AGE: Cardiovascular Risk Linked to Poor Memory Independently of Age in HIV+ - Written by Mark Mascolini - (11/14/13)
     
  431. AGE: Carotid Plaques Develop More Often With vs Without HIV in Metabolic Syndrome Patients - Written by Mark Mascolini - (10/31/13)
     
  432. AGE: "Successful Cognitive Aging" in Only One Fifth of US HIV Group 50 or Older - Written by Mark Mascolini - (10/31/13)
     
  433. EACS: Twice-Higher Latest Vitamin D Almost Halves Odds of Death in EuroSIDA - Written by Mark Mascolini - (10/21/13)
     
  434. High sensitive CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study - (07/20/13)
     
  435. CROI: CMV and HIV Infections Have Opposite Effects on CD8+ T Cell Differentiation and Proliferation - (06/23/13)
     
  436. CROI: Phenotypic CD8+ T cell Defects in Treated HIV Infection are Distinct from Those of Aging, Predict Mortality, and May Be Prevented by Earlier ART - (06/23/13)
     
  437. People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010 - (05/29/13)
     
  438. Autonomic Nervous System Dysfunction & Inflammation: Autonomic-mediated immunomodulation and potential clinical relevance - (05/29/13)
     
  439. CROI: CROI 2013: Comorbidities- Aging/Kidney/Heart/Belly Fat/HCV/Bone/Statins/Frailty - (05/27/13)
     
  440. Association of kidney disease measures with poor outcomes - (10/09/12)
     
  441. CROI: Metabolics, Inflammation, Complications, and Aging at CROI - written by David Alain Wohl, MD - The University of North Carolina - (04/03/11)
     
  442. The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus - (03/23/12)
     
  443. CROI: Impact of HAART Initiation on Immune Regulation (activation/senescence) in Aging HIV-infected Women -Women's Interagency HIV Study - (03/16/11)
     
  444. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence - Review - (02/07/12)
     
  445. Coping with HIV/Aging: managing health & psychological factors & HCV - (01/15/12)
     
  446. AntiAging Cancer Drug - Ageing: A midlife longevity drug? - (01/02/12)
     
  447. A New Link Between Aging Cells and Aging People - (01/02/12)
     
  448. HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated With Increased Multimorbidity Among Aging Injection Drug Users (ALIVE Study): unrecognized high rates of of multucomordibities - (11/28/11)
     
  449. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders - (11/04/11)
     
  450. 4 Aging Published Reports This Week: - (10/27/11)
     
  451. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy - (10/05/11)
     
  452. Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients - (09/29/11)
     
  453. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women - (09/19/11)
     
  454. Immune Activation Impairs CD4 Recovery & Increases Mortality - (09/07/11)
     
  455. Even Short Workout (15 minutes) Could Extend Life Expectancy - (08/19/11)
     
  456. Minimum amount (15 minutes) of physical activity for reduced mortality and extended life expectancy: a prospective cohort study - (08/19/11)
     
  457. Editorial - Survival benefit associated with low-level physical activity: "the direct health benefits of exercise are irrefutable. Exercise can reduce cardiovascular mortality and, in particular, coronary mortality by many mechanisms, including improvements in endothelial function, autonomic tone, inflammation, and risk-factor control" - (08/19/11)
     
  458. The Stanford HIV Aging Cohort Recruiting - (08/02/11)
     
  459. IAS: Biomarkers Predict Hepatic Flares and Death in Hepatitis-Coinfected People Starting ART - written by Mark Mascolini - (07/26/11)
     
  460. A Frailty-Related Phenotype Before HAART Initiation as an Independent Risk Factor for AIDS or Death After HAART Among HIV-Infected Men - pdf attached - (07/05/11)
     
  461. Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism - (07/05/11)
     
  462. Senescent phenotypes and telomere lengths of peripheral blood T-cells mobilized by acute exercise in humans - (07/05/11)
     
  463. Aging, Persistent Viral Infections, and Immunosenescence: Can Exercise ''Make Space''? - (07/05/11)
     
  464. Updated HRSA Guide for HIV/AIDS Clinical Care/Comorbidities now Available Online - see excerpted highlights on comorbidities below - (06/13/11)
     
  465. Vitamin D Ups Bisphosphonate Response (from Jules: and calcium levels too perhaps) - (06/13/11)
     
  466. AIDS survivors suffer premature aging, Needs/NIH Response - (06/13/11)
     
  467. Growing Older With H.I.V. - (06/13/11)
     
  468. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study: Vit D levels associated with HIV progression & mortality - (06/13/11)
     
  469. Premature aging seen as issue for AIDS survivors - (06/13/11)
     
  470. Exercise and inflammation - (05/26/11)
     
  471. Fighting Inflammation - diet & exercise - (05/26/11)
     
  472. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals: 'and to CD4 change after starting ART' - pdf attached - (05/19/11)
     
  473. Low Vitamin D Levels Seen in Parkinson's Patients - full text of study below - - (05/19/11)
     
  474. Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality: "Women in the highest vitamin D quintile had a 42% lower risk of all-cause mortality, compared to the lowest quintile. Vitamin D status had a protective association with HIV disease progression, all-cause mortality" - (05/19/11)
     
  475. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment - - (04/23/11)
     
  476. CROI: Risk of Stage 1 AIDS Dementia 12% Over 2 Years in Asymptomatic People - written by Mark Mascolini - (03/22/11)
     
  477. CROI: Carotid Atherosclerosis Is Related to HIV Duration and Anti-inflammatory Profile and Not to ARV Exposure: The CHIC Controlled Study - (03/17/11)
     
  478. CROI: D-dimer Levels Correlate with Inflammatory and Endothelial Activation Markers in HIV-infected Adults - (03/17/11)
     
  479. CROI: Coronary Artery Plaque Linked to Low Fat in MACS Men With HIV - written by Mark Mascolini - (03/15/11)
     
  480. CROI: Chronic Inflammation and HIV: CROI 2011 - David H. Shepp, MD Associate Professor of Medicine Hofstra North Shore-LIJ School of Medicine (03/11/11)
     
  481. HIV and Cancer in Germany - pdf attached - (03/10/11)
     
  482. CROI: Higher Fracture Rate With HIV + HCV Than With Either Virus Alone written by Mark Mascolini - (03/1/11)
     
  483. High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial - pdf attached - (02/26/11)
     
  484. Statins as Anti-inflammatory Therapy in HIV Disease? Editorial - pdf attached - (02/26/11)
     
  485. The Dual Impact of HIV-1 Infection and Aging on Naïve CD4+ T-Cells: Additive and Distinct Patterns of Impairment - From the Multicenter AIDS Cohort - (02/26/11)
     
  486. Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial - pdf attached - (02/18/11)
     
  487. Testosterone Treatment of Older Men-Why Are Controversies Created? Editorial - (02/18/11)
     
  488. Do the Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, And Quality of Life Persist Six Months after Treatment in Intermediate-Frail and Frail Elderly Men? - pdf attached - (02/18/11)
     
  489. Why Is Androgen Replacement in Males Controversial? - CLINICAL REVIEW- pdf attached - (02/18/11)
     
  490. Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis - pdf attached - (02/06/11)
     
  491. HIV Infection, Inflammation, Immunosenescence, and Aging - pdf attached - (02/06/11)
     
  492. 1st Int. Workshop on HIV & Aging Published REPORT pdf attached. 4 -5 October 2010, Baltimore, USA - (01/27/11)
     
  493. Increasing incidence of ischemic stroke in patients with HIV infection: HIV, HAART, metabolics, median age 50, absolute numbers small - pdf attached - (01/20/11)
     
  494. Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence among Adults in the US General Population - pdf attached (this was presented in poster at CROI) - (01/14/11)
     
  495. The Effect of Antiretrovirals on Vitamin D - pdf attached - (01/14/11)
     
  496. HIV & Aging Slide Talk CME - (01/12/11)
     
  497. Fractures In Aging >50 Yrs Old: associated with antiepileptic drugs, comorbidities, hypertension osteoprotective - pdf attached - (01/12/11)
     
  498. Aging with HIV: As HIV population grows older, diseases of aging are a new dilemma New Aging Study/Clinic at SFGH - (01/08/11)
     
  499. Inflammation (lipodystrophy) Associated with Physical Performance Decline - (01/05/11)
     
  500. Gait speed was associated with survival in older adults - (01/05/11)
     
  501. Aging HIV, Diabetes and Kidney Disease - (12/22/10)
     
  502. Higher HDL-C levels may curb Alzheimer's disease risk - (12/22/10)
     
  503. Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease - pdf attached - (12/22/10)
     
  504. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health (vit D insufficiently defined)- publication pdf attached - (12/22/10)
     
  505. Marijuana Component Eases Diabetic Heart Woes - pdf publication attached - (12/13/10)
     
  506. Insulin metabolism and the risk of Alzheimer disease - full txt from Neurology below pdf attached - (12/05/10)
     
  507. 10th Congress Drug Therapy HIV: Nevirapine Versus Ritonavir-Boosted Atazanavir CombinedWith Tenofovir/ Emtricitabine in First-LineTherapy: NEWART 48-Week Data - (12/05/10)
     
  508. Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection - published pdf attached - (11/29/10)
     
  509. The Lesser-Known Complications (Bone) of HIV/AIDS (aging, complications) - (11/29/10)
     
  510. Telomerase reverses ageing process (full text; published pdf attached) - (11/29/10)
     
  511. White House Meeting on HIV/Aging - (11/01/10)
     
  512. Cancer and viral infections in immunocompromised individuals - pdf attached - (10/26/10)
     
  513. Cancer incidence and risk factors after solid organ transplantation - pdf attached - (10/26/10)
     
  514. Immunosenescence & Aging in HIV - (10/22/10)
     
  515. "initiating HAART at higher CD4 cell counts for older individuals may be useful- NA-ACCORD Study" - pdf attached - (10/18/10)
     
  516. Symposium: Optimizing Vitamin D Intake for Populations with Special Needs: Barriers to Effective Food Fortification and Supplementation - (10/16/10)
     
  517. Biomarkers of impaired renal function - pdf attached - (10/16/10)
     
  518. Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort - pdf attached - (10/16/10)
     
  519. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey - pdf attached - (10/16/10)
     
  520. Aging Wrkshp: CD4 Counts Lower on Entry Into Care Among People 50 and Older: NA-ACCORD - (10/13/10)
     
  521. Aging Wrkshp: Low Vitamin D Not Linked to Bone Density or Liver Fibrosis in HIV/HCV Group - Written by Mark Mascolini - (10/08/10)
     
  522. Aging Wrkshp: Multiple non-AIDS Diseases More Frequent in Aging IDUs With Versus Without HIV - Written by Mark Mascolini - (10/08/10)
     
  523. Aging Wrkshp: Family History of Dementia Predicts Worse Neuropsych Function With HIV (dementia defined below) - Written by Mark Mascolini - (10/08/10)
     
  524. Aging Wrkshp: Aging HIV+ Hospitalized More Often: Non-AIDS Infections, Heart and GI Disease Explain Most Hospitalizations in Over-50 People With HIV - Written by Mark Mascolini - (10/04/10)
     
  525. Aging Wrkshp: HIV-Infected in 40s Have Multiple Non-HIV Illnesses as Often as HIV-Negatives in 50s - Written by Mark Mascolini - (10/04/10)
     
  526. Aging Wrkshp: Comorbidity Rates Higher in Over-49 HIV Group Than in Matched HIV Negatives - Written by Mark Mascolini - (10/04/10)
     
  527. HIV and Premature Aging: A Field Still in Its Infancy - Editorial: "Age at Cancer Diagnosis Among Persons With AIDS in the United States" (pdf of published study attached) - (10/06/10)
     
  528. Aging Wrkshp: Sexual Function Worse With HIV Than Diabetes or No Chronic Illness in Older Men - Written by Mark Mascolini - (10/06/10)
     
  529. Aging Wrkshp: Older Age, HIV, and Antiretrovirals Linked to Neurodegenerative Marker - Written by Mark Mascolini - (10/06/10)
     
  530. Aging Wrkshp: More Non-HIV Illnesses With HIV Than Without, But Less Treatment; New HCV therapy will add to burden - Written by Mark Mascolini - (10/06/10)
     
  531. Aging Wrkshp: Older Women With HIV Report "Premature Aging" Strikingly More Often Than Men - Written by Mark Mascolini - (10/06/10)
     
  532. Aging Wrkshp: Higher Risk of Potential Drug-Drug Interactions in Toronto HIV Patients Over 60 - Written by Mark Mascolini - (10/05/10)
     
  533. Aging Wrkshp: Lipoatrophy and Efavirenz Tied to Vitamin D Deficiency in Ontario - Written by Mark Mascolini - (10/05/10)
     
  534. Aging Wrkshp: Pretreatment CD4s and CD4/CD8 Ratio Lower in Trial Participants Over 50 - Written by Mark Mascolini - (10/05/10)
     
  535. Aging Wrshp: Age Raises Fracture Risk More in People With Than Without HIV - Written by Mark Mascolini - (10/05/10)
     
  536. Coronary Aging in HIV-Infected Patients - (09/23/10)
     
  537. Coronary Aging in HIV-Infected Patients: "Increased vascular age was observed in 162 patients (40.5%), with an average increase of 15 years"...."you are 50 years old but your heart's age is 65" - pdf attached - (09/23/10)
     
  538. Immune senescence in aged nonhuman primates Review - (09/23/10)
     
  539. Prevalence and Correlates of Sexual Behavior and Risk Management Among HIV-Positive Adults Over 50 - pdf attached - (09/23/10)
     
  540. Persistence of Racial Differences in Attitudes Toward Homosexuality in the United States.....may help to explain disparities in HIV-infection rates between black & white MSM - pdf attached - (09/23/10)
     
  541. Ageing and HIV/AIDS (Aging/HIV Clinic in London): A dedicated clinical service for HIV-infected individuals over 50 years of age (09/16/10)
     
  542. NIH statement on National HIV/AIDS and Aging Awareness Day Sept. 18, 2010 - not good enough - (09/15/10)
     
  543. Aging Exacerbates Extrapyramidal Motor Signs in the Era of HAART - (09/13/10)
     
  544. PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY - (09/13/10)
     
  545. New UCSF Anal Cancer Information Website - (09/09/10)
     
  546. Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice - (09/09/10)
     
  547. Oral bisphosphonates and oesophageal cancer - 'evidence inconclusive' Editorial - (09/09/10)
     
  548. Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer - 2nd study 'no difference in risk' - (09/09/10)
     
  549. Here is a booklet out of the UK from Mike Youle's group on Aging with helpful information on aging with or without HIV. - (08/29/10)
     
  550. Diabetes, Insulin Resistance Linked to Alzheimer's - (08/29/10)
     
  551. High Rates of Asymptomatic Neurocognitive Impairment in Vertically Acquired HIV-1-Infected Adolescents Surviving to Adulthood - (08/29/10)
     
  552. Older Patients' Share of Office Visits Grows: Care Services for Aging Increased Demand - (08/15/10)
     
  553. Cognitive Decline Biomarkers-HIV Studies Needed !!!! - (08/13/10)
     
  554. C-Reactive Protein Levels Increase During HIV-1 Disease Progression in Rakai, Uganda, Despite the Absence of Microbial Translocation - publication pdf attached - (08/07/10)
     
  555. Alzheimer disease and HIV A tangled story - Editorial - (07/15/10)
     
  556. HIV & Alzheimers: are HIV+ At Greater Risk for Alzheimers - pdf full text attached - (07/14/10)
     
  557. HIV/Aging & Antiaging Therapy - (07/12/10)
     
  558. Inflammation Predicts Mortality in FRAM - (07/08/10)
     
  559. Depression doubles risk of dementia - (07/07/10)
     
  560. Telomere Length and Risk of Incident Cancer and Cancer Mortality - (07/08/10)
     
  561. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment - (07/07/10)
     
  562. Depressive symptoms and risk of dementia - The Framingham Heart Study - (07/07/10)
     
  563. New Gene Therapy Zinc Fingers Research Published: 'doctors may someday control HIV virus using stem cells without using anti-retroviral drugs' - (07/07/10)
     
  564. Immunosenescence and Vaccination - Commentary - (06/29/10)
     
  565. Mechanisms of immunosenescence Short report - (06/29/10)
     
  566. Immunosenescence comes of age. Symposium on Aging Research in Immunology: The Impact of Genomics - (06/23/10)
     
  567. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes' - (06/23/10)
     
  568. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation - (06/23/10)
     
  569. HIV-associated lipodystrophy: from fat injury to premature aging - Review - pdf of article attached - (06/22/10)
     
  570. Mitochondrial Dysfunction in HIV+ CNS/Muscular Organ Systems Disorders in HIV+ Children, and perhaps related to accelerated aging in older HIV+ adults - (06/20/10)
     
  571. Beyond Hemoglobin A1c-Need for Additional Markers of Risk for Diabetic Microvascular Complications - commentary - (06/08/10)
     
  572. Circulating mitochondrial DAMPs cause inflammatory responses to injury - (06/07/10)
     
  573. "mitochondria.....might initiate inflammation....mitochondria are probably released in patients with infectious disease" - (06/07/10)
     
  574. Immunology & Mitochondria - Clinical immunology: Culprits with evolutionary ties - (06/07/10)
     
  575. The Mitochondrion - A Trojan Horse That Kicks Off Inflammation? - (06/07/10)
     
  576. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model - (05/12/10)
     
  577. Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection - (05/07/10)
     
  578. Inflammation and Complications of HIV Disease - EDITORIAL COMMENTARY - (05/07/10)
     
  579. Pre-HAART Immune Activation Associated with Developing Cancers & Death - (05/07/10)
     
  580. CROI: T cell Senescence and Proliferation Defects Persist in Treated HIV-infected Individuals Maintaining Viral Suppression and Are Associated with Poor CD4+ T Cell Recovery - (03/01/10)
     
  581. CROI: Impact of CD8+ T Cell Activation on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating Antiretroviral Therapy - (03/01/10)
     
  582. CROI: Valganciclovir Reduces CD8+ T Cell Activation among HIV-infected Patients with Suboptimal CD4+ T cell Recovery During Antiretroviral Therapy - (03/01/10)
     
  583. Early Immune Senescence in HIV Disease - (02/15/10)
     
  584. Immunosupportive therapies in aging - pdf attached - (02/05/10)
     
  585. Protein in Urine Presages More Severe Problems - free full text link below - (02/04/10)
     
  586. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women (and men) - (01/29/09)
     
  587. HIV Infection and Aging Independently Affect Brain Function as Measured by Functional Magnetic Resonance Imaging - BRIEF REPORT - (01/25/09)
     
  588. Quality-Of-Life Predicts Survival in HIV: HIV & aging - (01/17/09)
     
  589. Aerobic Exercise Improved Cognitive Function in Older Adults with Mild Cognitive Impairment - (01/17/09)
     
  590. Moderate Mid-Life Exercise Prevents Mild Cognitive Impairment - (01/17/09)
     
  591. Testosterone: More Is Not Always Better - EDITORIAL - (12/21/09)
     
  592. Thyroid Function and Longevity: New Insights into an Old Dilemma - EDITORIAL - (12/21/09)
     
  593. Mediterranean Diet and Late-Life Cognitive Impairment -Editorial - (12/09/09)
     
  594. Physical Activity, Diet, and Risk of Alzheimer Disease: In this study, both higher Mediterranean-type diet adherence and higher physical activity were independently associated with reduced risk for AD. - (12/09/09)
     
  595. Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall - (12/01/09)
     
  596. Cardiovascular Diseases and Risk of Hip Fracture - (10/27/09)
     
  597. Diabetes Can Impair Exercise Capacity: Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus - (10/07/09)
     
  598. Subcutaneous (lipoatrophy) Rather than Visceral Adipose Tissue Is Associated with Adiponectin Levels and Insulin Resistance in Young Men - (10/07/09)
     
  599. Sex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) Study - (10/07/09)
     
  600. Frontostriatal fiber bundle compromise in HIV infection without dementia - (10/06/09)
     
  601. Lipoatrophy & Mortality, CVD - (09/30/09)
     
  602. Diabetes 2 Caused Brain Atrophy in Older Individuals - (09/30/09)
     
  603. HIV and Aging: The Long-term Consequences of Successful Antiretroviral Therapy - (09/11/09)
     
  604. HIV, HAART & Brain Damage & Repair - (09/11/09)
     
  605. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people - (08/29/09)
     
  606. Neurological Impairment Persists Despite HAART: "adjunctive therapies needed" - (08/29/09)
     
  607. Insulin Resistance Is Associated With Cognition Among HIV-1-Infected Patients: The Hawaii Aging With HIV Cohort - (08/29/09)
     
  608. HCV Coinfection & Neurologic Impairment - (08/29/09)
     
  609. 5th IAS: Prevalence of HIV-1-Associated Neurocognitive Disorders in Argentina - (08/27/09)
     
  610. Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss - pdf attached - (08/27/09)
     
  611. The clot thickens-oxidized lipids and thrombosis - (08/26/09)
     
  612. Oxidized lipids: a key to heart disease? - (08/26/09)
     
  613. Aging/HIV Clinical Care & Research - New IDSA Guidelines - (08/26/09)
     
  614. Thyroid Dysfunction, Hypogonadism, Testosterone, Bone, Prostate Cancer, HIV & HAART - (08/26/09)
     
  615. Aging & HIV Recognized as a Serious Concern But No Real Discussion, Still Ignored. 2007 NIH Workshop recommendations - (08/26/09)
     
  616. NIH Workshop on HIV in Older Adults Oct 20 2007 - (08/18/09)
     
  617. A serum 25-hydroxyvitamin D level below 50 nmol/l has been associated with increased body sway and a level below 30 nmol/l with decreased muscle strength. - (08/18/09)
     
  618. Vitamin D deficiency, muscle function, and falls in elderly people1,2 Review Article - (08/18/09)
     
  619. 5th IAS: One Third With Undetectable HIV RNA Have Asymptomatic Neurocognitive Impairment - written by Mark Mascolini - (07/20/09)
     
  620. 5th IAS: Thinking Through the CNS: The Importance of Considering the Blood-Brain Barrier. Slide talk by Scott Letende, GSK satellite meeting at IAS 2009 - (07/19/09)
     
  621. 5th IAS: European Researchers Issuing Guidelines on Bone Disease - (07/19/09)
     
  622. HIV-1 Infection Is Associated With an Earlier Occurrence of Frailty....in MACS - (07/18/09)
     
  623. Growth Hormone and Sex Steroid Effects on Serum Glucose, Insulin, and Lipid Concentrations in Healthy Older Women and Men - (07/16/09)
     
  624. MRI Findings May Track Risk of Cognitive Impairment in Healthy Seniors - (07/16/09)
     
  625. Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men - (07/16/09)
     
  626. Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men - (07/16/09)
     
  627. Nitrates May Be Environmental Trigger For Alzheimer's, Diabetes And Parkinson's Disease - (07/08/09)
     
  628. Global Consequences of the Future of Aging with HIV - (07/08/09)
     
  629. A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection - full text pdf attached - (07/07/09)
     
  630. IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection - pdf full text attached - (07/07/09)
     
  631. IL-21 Is Required to Control Chronic Viral Infection - pdf full text attached - (07/07/09)
     
  632. Immunology Controlling Chronic Viral Infections, EDITORS' CHOICE - (07/07/09)
     
  633. A Chronic Need for IL-21 EDITORIAL - (07/07/09)
     
  634. Metabolic bone disease in HIV infection: HIV, ART Implicated EDITORIAL - (07/02/09)
     
  635. First line AZT/3TC/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir - (07/02/09)
     
  636. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (07/02/09)
     
  637. Inflammation Marker hsCRP & CVD- Cause or Effect: Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease - (07/02/09)
     
  638. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community: "Minimal Benefit In Predicting CVD Compared To Traditional Risk Factors" - (07/02/09)
     
  639. Biomarkers and Cardiovascular Disease: Determining Causality and Quantifying Contribution to Risk Assessment - Editorial - (07/02/09)
     
  640. CRP, other biomarkers, not clinically useful to predict CVD risk - (07/02/09)
     
  641. New meta-analysis: Statins of benefit in primary prevention: improved survival & CVD risk in patients with only risk factors - (07/02/09)
     
  642. Monitoring bone mineral density during antiresorptive treatment for osteoporosis - Editorial - (06/27/09)
     
  643. Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data - (06/27/09)
     
  644. The Value of Bone Density Testing - (06/27/09)
     
  645. Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys - (06/19/09)
     
  646. Study in Neurology journal (Aug 2008) Reports Alzheimers Appears to Precede Frailty and Study in Jnl of Geronotology (2007) in the MACS Cohort Reports Risk of Frailty Higher in HIV+ vs HIV-; is early onset of Alzheimers or some other brain or cognitive dysfunction related to early onset and higher rates of frailty among HIV+? - (06/08/09)
     
  647. Antiaging Therapy with TAT2: Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes - (06/02/09)
     
  648. Modulation of T Lymphocyte Replicative Senescence via TNF-{alpha} Inhibition: Role of Caspase-31 - (06/01/09)
     
  649. Does HIV Increase Prostate Cancer Risk? - (05/21/09)
     
  650. Effects of Oxidation and Inflammation, Cancer, Prostate Cancer - (05/21/09)
     
  651. Predicting risk of dementia in older adults. The late-life dementia risk index - Aging !!!! - (05/15/09)
     
  652. RNA Testing for HIV Instead of Antibody Testing Could Detect Early Stage of HIV Infection And Would Likely Improve Prevention AND Allow for Early HAART' Could it Prevent Accelerated Aging? - (05/13/09)
     
  653. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS (case study) - (05/13/09)
     
  654. Cancers in HIV Review in AIDS May 15 2009 - (05/13/09)
     
  655. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial - (05/13/09)
     
  656. Glucocorticoid-induced osteoporosis: hope on the HORIZON-COMMENT - (04/20/09)
     
  657. Reversing HIV T-Cell Aging - (04/20/09)
     
  658. HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty: HIV+ men in MACS 10-Times More Likely to Exhibit Frailty than HIV-negative Men. - (04/20/09)
     
  659. MACS Frailty/HIV/CD4 Study Misses The Point - (04/20/09)
     
  660. Midlife Patients With HIV or AIDS Require Care for Chronic Conditions: "HIV simulates aging" - (03/27/09)
     
  661. ISHLVD: Developing HBV/HCV Associated Liver Cancer At A Young Age < 40 Yrs Old - (03/25/09)
     
  662. How Inflammatory Disease Causes Fatigue: chronic inflammation infiltrates the brain but can be blocked - (03/10/09)
     
  663. WHO | The unexplored story of HIV and ageing - (03/05/09)
     
  664. CROI: Effects of Aging on HIV-1 Pathogenesis: HIV causes inflammation & T-cell activation, reported here to be more in postmenopausal women - (03/04/09)
     
  665. CROI: Immune Senescence, Activation and Abnormal T cell Homeostasis Despite Effective HAART, A Hallmark of Early Aging in HIV Disease - (03/03/09)
     
  666. HAART Does Not Reverse Premature T-Cell Aging Caused by HIV - (02/27/09)
     
  667. Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment - (02/27/09)
     
  668. CROI: Aging with HIV - Lessons from CROI 2009 - Victor Valcour MD - (02/27/09)
     
  669. CROI: HIV Infection May Make the Brain 15 to 20 Years Older: HIV slows cerebral blood flow and stimulus response in MRI study - written by Mark Mascolini - (02/23/09)
     
  670. CROI: Effects of Aging on HIV Pathogenesis: aging is associated with higher t-cell activation in women than men, effects of menopause on inflammation and immune activation...." (02/23/09)
     
  671. CROI: Immune Senescence, Activation, and Abnormal T Cell Homeostasis despite Effective HAART, a Hallmark of Early Aging in HIV Disease: "HIV-infected subjects (median 56 years) with good immune reconstitution and viral suppression had immune changes comparable to older (median 88 years) HIV-negative subjects" - (02/20/09)
     
  672. CROI: HIV-1 INFECTION IS ASSOCIATED WITH ACCELERATED VASCULAR AGING (02/18/09)
     
  673. CROI: Neurocognitive (and neuropathy) Impairment Rate Remains High in Diverse US Cohort - written by Mark Mascolini - (02/18/09)
     
  674. Causes of Accelerated Aging in HIV: HIV Induces Aging of T-Cells - (02/10/09)
     
  675. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity: review by Steve Deeks and Andrew Phillips - (01/28/09)
     
  676. Aerobic + Strength Exercise is Optimal for Insulin Resistance and Improved Health & Frailty in Study of Obese and Older, Average Age 67 Yrs - (01/28/09)
     
  677. HIV Prematurely Accelerates Aging - (01/22/09)
     
  678. AGING AND INFECTIOUS DISEASES: effects of aging; Immunosenescence and Vaccination in Nursing Home Residents - (01/22/09)
     
  679. Our results suggest that HIV-1 infection induces an accelerated aging of T lymphocytes, which is associated with the clinical progression to AIDS and death - (01/13/09)
     
  680. C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study - (01/14/09)
     
  681. Cardiovascular Complications in HIV Management: Past, Present, and Future [Critical Review: Clinical Science] - (01/12/09)
     
  682. Increased Melanoma Rates in USA Are Real and Aging/HIV - (01/09/09)
     
  683. Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women - (01/07/09)
     
  684. Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy - (01/02/09)
     
  685. Keeping Blood Sugar Low May Help Stem Geriatric Memory Loss - (01/02/09)
     
  686. Central obesity and increased risk of dementia more than three decades later - (12/22/08)
     
  687. Visceral Fat & Neurotoins, Insulin Resistance & Alzheimer Disease/Dementia EDITORIAL - (12/22/08)
     
  688. Impaired insulin secretion increases the risk of Alzheimer disease - (12/22/08)
     
  689. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes - (12/22/08)
     
  690. Associations between Male Anogenital Human Papillomavirus Infection and Circumcision by Anatomic Site Sampled and Lifetime Number of Female Sex Partners - (12/22/08)
     
  691. Federal Government NIAID Aging Funding Opportunities - (12/16/08)
     
  692. Neurological/Cognitive Impairment on HAART: 50% on HAART have cognitive impairment - (12/10/08)
     
  693. 10th Intl Workshp Adverse Drug Reactions & Lipo: A Comparison of Cardiac Function Between HIV-Infected and HIV-Seronegative People With and Without the Metabolic Syndrome. - (12/10/08)
     
  694. 10th Intl Workshp Adverse Drug Reactions & Lipo: COMPARISON OF THE EFFECTS OF NEVIRAPINE RESPECT TO EFAVIRENZ ON DIFFERENTIATING AND MATURE HUMAN ADIPOCYTES IN CULTURE - (12/10/08)
     
  695. Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy - (12/09/08)
     
  696. "elevations in inflammatory markers seen in insulin resistance, metabolic syndrome, and diabetes are not causative but a consequence of these abnormalities." - (12/02/08)
     
  697. Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes - (12/02/08)
     
  698. Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and Lipoatrophy - (12/02/08)
     
  699. Inflammation May Be Associated with AIDS Progression - (12/02/08)
     
  700. Uric Acid Levels Increase Risk for New-Onset Kidney Disease - Editorial - (12/02/08)
     
  701. HIV TAT Protein Infects Brain Shortly After HIV-Infection and Disrupts Brain Normal Activity, Affects Mitochondria-- Pretreatment with the RyR antagonist, dantrolene mediated these pathologic effects.....dantrolene has side effects but these findings could lead to research for therapy to block this mechanism of action "RyR may be a crucial target for neuroprotection in HIV-associated neurologic disease" - (11/19/08)
     
  702. ICAAC: Continuous Antiretroviral Therapy Decreases Bone Mineral Density: Results from the SMART Study (11/24/08)
     
  703. ICAAC: Bone Loss in SMART Study - Written by Mark Mascolini - (10/30/08)
     
  704. Statin induced myopathy - (11/21/08)
     
  705. 10th Intl Workshp Adverse Drug Reactions & Lipo: Effect of HAART on insulin sensitivity, autonomic nervous system function and beta-adrenergic mediated lipolysis (11/20/08)
     
  706. Statin (Crestor) Prevents Heart Disease, Lowers LDL and Inflammation in Healthy with Normal Lipids - (11/18/08)
     
  707. Statin Therapy for Prevention? EDITORIAL Expanding the Orbit of Primary Prevention - Moving beyond JUPITER - (11/18/08)
     
  708. JUPITER hits New Orleans: Landmark study shows statins benefit healthy individuals with high CRP levels - (11/18/08)
     
  709. Crestor Study Will Boost Statin Demand - (11/18/08)
     
  710. The role of HIV in serious diseases (non-AIDS diseases) other than AIDS - (11/18/08)
     
  711. Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies - (11/18/08)
     
  712. Higher frequency of dementia in older HIV-1 individuals The Hawaii Aging with HIV-1 Cohort - (11/18/08)
     
  713. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis - (11/18/08)
     
  714. Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection - (11/18/08)
     
  715. 9th Interntl Drug Thrpy HIV: Cardiovascular disease; HIV, ART, immunodeficiency, pro-inflammation and other factors - (11/13/08)
     
  716. ICAAC: Unremitting Kaposi Sarcoma in HIV infected patients with viral suppression on antiretrovirals - (10/31/08)
     
  717. Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia - (10/24/08)
     
  718. The CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study - (10/23/08)
     
  719. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients - (10/23/08)
     
  720. Neurotoxic effect of HIV: HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people - (10/23/08)
     
  721. The prevalence and incidence of neurocognitive impairment in the HAART era (08/30/07)
     
  722. More Alzheimer's Risk for Hispanics, Studies Suggest - (10/21/08)
     
  723. Diabetes in D.A.D. Study - (10/21/08)
     
  724. Non-AIDS Deaths In HIV Positive Patients Linked To Inflammation And Coagulation Markers...and ART interruption - (10/21/08)
     
  725. Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients - (10/21/08)
     
  726. Association of White Blood Cell Subfraction Concentration with Fitness and Fatness - (10/17/08)
     
  727. Aging with HIV Increases Risk for Comorbidities: Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity? - (10/14/08)
     
  728. CROI: HIV and Aging at CROI 2008 - epidemiology of aging with HIV - (02/22/08)
     
  729. Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes - (10/10/08)
     
  730. Mitochondria and Aging - (10/09/08)
     
  731. New Genetic Model For Parkinson's Disease: mitochondrial damage - (10/09/08)
     
  732. Mitochondria Damage & Aging - (10/09/08)
     
  733. Reports of KS in Aging SF Patients - (10/06/08)
     
  734. Can We Cure Aging? - (10/06/08)
     
  735. Central obesity and increased risk of dementia more than three decades later - (10/03/08)
     
  736. Impaired insulin secretion increases the risk of Alzheimer disease - (10/03/08)
     
  737. Visceral Adiposity & Insulin Impairment & Dementia/Alzheimer's - (10/03/08)
     
  738. Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study - (09/2/08)
     
  739. Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America - (05/13/05)
     
  740. Cancers in HIV: immunity/ART - (09/26/08)
     
  741. Estimating GFR Using Cystatin Alone & in Combination with Creatinine: analysis of 3,418 with CKD - (09/26/08)
     
  742. Chronic Kidney Disease Prevalence Higher in the USA: related to hypertension, diabetes, aging - (09/26/08)
     
  743. CKD in the Elderly-Old Questions and New Challenges: CKD in the elderly as a new challenge for research, clinical practice, and public health. - (09/26/08)
     
  744. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis - (09/26/08)
     
  745. CROI: Incidence Anal Squamous Intraepithelial Lesions (SIL) and Predictors of in the SUN Study after One Year of Follow-up - (02/22/08)
     
  746. CROI: Immunodeficiency and Risk of AIDS-defining and Non-AIDS-defining Cancers: ANRS CO3 Aquitaine Cohort, 1998 to 2006 - (02/25/08)
     
  747. CROI: Insufficient Virus Suppression during HAART Is a Strong Predictor for the Development of AIDS-related Lymphoma: German CLINSURV Cohort - (02/25/08)
     
  748. CROI: Fat Changes Boost Heart Disease and Diabetes Risk in HIV-Infected Men - Written by Mark Mascolini (02/19/08)
     
  749. CROI: Cardiovascular Risk Markers Greatly Inflate Death Risk in People With HIV; interruptions increase risk - Written by Mark Mascolini (02/12/08)
     
  750. CROI: Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis - (03/07/08)
     
  751. CROI: Prevalence and Risk Factors in HIV-infected Persons for Echocardiographic Abnormalities in the Era of Modern HAART - (03/05/08)
     
  752. CROI: Inflammatory Markers Correlate with Carotid Intima-Media Thickness and Endothelial Activation in HIV-infected Patients (03/12/08)
     
  753. Subclinical Glucose Abnormalities & Undiagnosed Diabetes Noted in HCV+ - (09/18/08)
     
  754. Vitamin B12 & Brain Atrophy - (09/18/08)
     
  755. Alzheimer's Disease Risk Factors: metabolics-diabetes, cholesterol--, genetics, lifesyle - (09/18/08)
     
  756. Mediterranean Diet Improves Health & Mortality - (09/18/08)
     
  757. HIV, Dementia & HAART - (09/18/08)
     
  758. Intensive Blood Glucose Control Has Positive Outcomes in ADVANCE Study - (09/12/08)
     
  759. Aging with HIV; Early Cognitive Decline - (08/28/08)
     
  760. Depression in the United States Household Population, 2005-2006 - (09/16/08)
     
  761. HIV-associated Alzheimer's disease in the Future? - (09/16/08)
     
  762. Statins for Slowing Kidney Disease Progression: An as yet Unproven Indication - (09/16/08)
     
  763. Frailty Defined in Older Adults Evidence for a Phenotype - (09/16/08)
     
  764. Physical Frailty Could Predict Alzheimer's Disease - (09/16/08)
     
  765. Alzheimer's Disease Risk Factors: exercise, metabolics, lifestyle, genetics - (09/16/08)
     
  766. ACTG Bone Study Group Established; More Bone Issues Need Attention - (09/18/08)
     
  767. Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy: Results of an Observational Multicenter Study - (09/18/08)
     
  768. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis - (09/12/08)
     
  769. Approach to the Patient with Prediabetes - (09/08/08)
     
  770. HCV Coinfection Increases Risk for HIV-Related Kidney Disease - (09/18/08)
     
  771. The Inflammatory Debate: Is it the Virus, the Drugs, or the Host? - (09/18/08)
     
  772. Highly-sensitive C-reactive protein (hsCRP) is associated with body mass index (BMI) and serum lipids in HIV-infected patients with low cardiovascular disease (CVD) risk and virologic suppression on antiretroviral therapy (ART) - (09/18/08)
     
  773. Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The Mortalite 2000 and 2005 Surveys (ANRS EN19 and Mortavic) [Epidemiology and Social Science] - (08/27/08)
     
  774. Running slows the aging clock, Stanford researchers find - (09/02/08)
     
  775. Earlier HAART Suggested for African-Americans At-Risk for Kidney Disease - (08/27/08)
     
  776. HIV, HAART & Brain Damage - (09/18/08)
     
  777. Intensive Blood Glucose Control Has Positive Outcomes in ADVANCE Study - (09/18/08)
     
  778. Subclinical Glucose Abnormalities & Undiagnosed Diabetes Noted in HCV+ - (09/18/08)
     
  779. HIV Infection and Dementia in Older Adults: should we be concerned? - (04/25/06)
     
  780. HIV, HAART & Brain Damage - (11/28/05)